We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $156M Turnover 90.24%
1-Year Est. Return 14.89%
This Fund
S&P 500
This Quarter Est. Return
+11.62%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.1%
AUM
$409M
AUM Growth
-$44.1M
Cap. Flow
-$59.6M
Cap. Flow %
-14.56%
Top 10 Hldgs %
18.06%
Holding
781
New
279
Increased
97
Reduced
120
Closed
283
Avg Time Held
0.3 years
Top 10 Avg Time Held
0.1 years
Top 20 Avg Time Held
0 years

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$10.8M
2
MSFT icon
Microsoft
MSFT
+$7.69M
3
TSM icon
TSMC
TSM
+$6.92M
4
ABBV icon
AbbVie
ABBV
+$6.78M
5
NKLA icon
Nikola Corporation Common Stock
NKLA
+$6.58M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$49.3M
2
BIIB icon
Biogen
BIIB
+$6.69M
3
ACN icon
Accenture
ACN
+$6.42M
4
TGT icon
Target
TGT
+$5.14M
5
DIS icon
Walt Disney
DIS
+$4.08M

Sector Composition

Rank Sector Weight
1 Technology 25.52%
2 Consumer Discretionary 16.31%
3 Healthcare 16%
4 Industrials 8.72%
5 Financials 8.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AAP icon
51
Advance Auto Parts
AAP
$2.68B
$1.75M 0.43%
11,400
+4,610
+68% +$694K
2020 Q1
2 quarters
HZNP
52
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.75M 0.43%
22,500
+3,100
+16% +$213K
2020 Q1
2 quarters
WYNN icon
53
Wynn Resorts
WYNN
$7.78B
$1.75M 0.43%
24,300
+14,100
+138% +$1.12M
2020 Q1
2 quarters
GILD icon
54
Gilead Sciences
GILD
$194B
$1.73M 0.42%
+27,400
New +$1.9M
2020 Q3
0 quarters
WST icon
55
West Pharmaceutical
WST
$27B
$1.65M 0.4%
6,000
-1,378
-19% -$365K
2019 Q3
4 quarters
CSCO icon
56
Cisco
CSCO
$423B
$1.62M 0.4%
+41,217
New +$1.8M
2020 Q3
0 quarters
BJ icon
57
BJs Wholesale Club
BJ
$13B
$1.61M 0.39%
+38,700
New +$1.6M
2020 Q3
0 quarters
NOW icon
58
ServiceNow
NOW
$147B
$1.6M 0.39%
16,500
-5,390
-25% -$481K
2020 Q1
2 quarters
NXPI icon
59
NXP Semiconductors
NXPI
$57.8B
$1.6M 0.39%
+12,800
New +$1.56M
2020 Q3
0 quarters
SYK icon
60
Stryker
SYK
$113B
$1.58M 0.39%
+7,605
New +$1.48M
2020 Q3
0 quarters
WDAY icon
61
Workday
WDAY
$46B
$1.57M 0.38%
+7,300
New +$1.44M
2020 Q3
0 quarters
NEM icon
62
Newmont
NEM
$125B
$1.54M 0.38%
+24,300
New +$1.58M
2020 Q3
0 quarters
DGX icon
63
Quest Diagnostics
DGX
$25.9B
$1.54M 0.38%
13,463
+10,163
+308% +$1.2M
2020 Q2
1 quarter
NSC icon
64
Norfolk Southern
NSC
$73.4B
$1.54M 0.38%
7,200
-1,500
-17% -$301K
2020 Q1
2 quarters
ABT icon
65
Abbott
ABT
$181B
$1.5M 0.37%
+13,800
New +$1.4M
2020 Q3
0 quarters
CB icon
66
Chubb
CB
$139B
$1.48M 0.36%
12,700
+7,363
+138% +$925K
2019 Q4
3 quarters
DBX icon
67
Dropbox
DBX
$7.73B
$1.46M 0.36%
75,900
-12,000
-14% -$250K
2020 Q1
2 quarters
LYFT icon
68
Lyft
LYFT
$6.37B
$1.45M 0.35%
+52,700
New +$1.57M
2020 Q3
0 quarters
NVAX icon
69
Novavax
NVAX
$1.86B
$1.45M 0.35%
+13,400
New +$1.63M
2020 Q3
0 quarters
HPQ icon
70
HP
HPQ
$27.1B
$1.45M 0.35%
76,147
+11,800
+18% +$215K
2020 Q1
2 quarters
GOTU icon
71
Gaotu Techedu
GOTU
$621M
$1.44M 0.35%
+16,000
New +$1.43M
2020 Q3
0 quarters
LW icon
72
Lamb Weston
LW
$7.38B
$1.43M 0.35%
21,645
+9,158
+73% +$587K
2020 Q2
1 quarter
EOG icon
73
EOG Resources
EOG
$82.9B
$1.38M 0.34%
+38,300
New +$1.72M
2020 Q3
0 quarters
MMM icon
74
3M
MMM
$85B
$1.36M 0.33%
+10,166
New +$1.37M
2020 Q3
0 quarters
AAL icon
75
American Airlines Group
AAL
$7.86B
$1.32M 0.32%
107,200
-48,339
-31% -$606K
2020 Q1
2 quarters

Similar funds

Bayesian Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Bayesian Capital Management held 781 positions worth $409M, down 9.7% from $453M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Bayesian Capital Management withdrew a net $59.6M in Q3 2020, closing 283 positions and reducing 120 holdings. Its most notable exit was Biogen, an estimated $6.69M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Bayesian Capital Management opened a new position in Apple worth $11.5M.

  • Bayesian Capital Management's largest Q3 2020 buy was Apple: 99,200 shares worth $11.5M.
  • Bayesian Capital Management added most to Microsoft in Q3 2020, an estimated $7.69M increase.
  • Bayesian Capital Management's biggest Q3 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $49.3M.
  • Bayesian Capital Management fully exited Biogen in Q3 2020, selling an estimated $6.69M.
  • Bayesian Capital Management's ten largest holdings make up 18% of its $409M portfolio in Q3 2020.
  • Bayesian Capital Management opened 279 new positions and closed 283 in Q3 2020.
  • Bayesian Capital Management's portfolio value fell 9.7% quarter-over-quarter to $409M.

Based on Bayesian Capital Management's 13F filing for Q3 2020, filed 12 Nov 2020.